Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-07-15 | New | $814,990 | $814,990 | Equity Only | 06b | SEC link |
2025-02-04 | New | $600,000 | $600,000 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
Joseph Hanssen | Director |
Matthew Laskowski | Director, Executive |
John Legget | Director |
Mark November | Director |
Dragan Sebisanovic | Director, Executive |